Azenta, Inc. Price to Sales Ratio 2010-2024 | AZTA
Historical PS ratio values for Azenta, Inc. (AZTA) over the last 10 years. The current P/S ratio for Azenta, Inc. as of February 21, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Azenta, Inc. P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-02-21 |
44.75 |
|
3.50 |
| 2024-12-31 |
50.00 |
$12.80 |
3.91 |
| 2024-09-30 |
48.44 |
$12.07 |
4.01 |
| 2024-06-30 |
52.62 |
$11.23 |
4.68 |
| 2024-03-31 |
60.28 |
$10.59 |
5.69 |
| 2023-12-31 |
65.14 |
$9.86 |
6.60 |
| 2023-09-30 |
50.19 |
$9.82 |
5.11 |
| 2023-06-30 |
46.68 |
$9.06 |
5.15 |
| 2023-03-31 |
44.62 |
$8.21 |
5.43 |
| 2022-12-31 |
58.22 |
$8.01 |
7.27 |
| 2022-09-30 |
42.86 |
$7.41 |
5.78 |
| 2022-06-30 |
72.10 |
$7.41 |
9.72 |
| 2022-03-31 |
82.88 |
$7.38 |
11.23 |
| 2021-12-31 |
103.11 |
$7.18 |
14.35 |
| 2021-09-30 |
102.26 |
$6.91 |
14.80 |
| 2021-06-30 |
95.08 |
$1.52 |
62.67 |
| 2021-03-31 |
81.40 |
$2.76 |
29.46 |
| 2020-12-31 |
67.55 |
$4.00 |
16.87 |
| 2020-09-30 |
45.99 |
$5.27 |
8.73 |
| 2020-06-30 |
43.89 |
$5.41 |
8.12 |
| 2020-03-31 |
30.19 |
$5.24 |
5.76 |
| 2019-12-31 |
41.42 |
$5.00 |
8.29 |
| 2019-09-30 |
36.46 |
$4.62 |
7.88 |
| 2019-06-30 |
38.05 |
$10.29 |
3.70 |
| 2019-03-31 |
28.73 |
$9.91 |
2.90 |
| 2018-12-31 |
25.56 |
$9.39 |
2.72 |
| 2018-09-30 |
34.08 |
$8.91 |
3.82 |
| 2018-06-30 |
31.65 |
$6.90 |
4.59 |
| 2018-03-31 |
26.19 |
$7.05 |
3.72 |
| 2017-12-31 |
22.98 |
$7.24 |
3.17 |
| 2017-09-30 |
29.14 |
$7.52 |
3.88 |
| 2017-06-30 |
20.74 |
$7.74 |
2.68 |
| 2017-03-31 |
21.34 |
$7.29 |
2.93 |
| 2016-12-31 |
16.19 |
$6.85 |
2.36 |
| 2016-09-30 |
12.83 |
$6.32 |
2.03 |
| 2016-06-30 |
10.49 |
$7.99 |
1.31 |
| 2016-03-31 |
9.64 |
$7.97 |
1.21 |
| 2015-12-31 |
9.80 |
$8.04 |
1.22 |
| 2015-09-30 |
10.65 |
$8.10 |
1.31 |
| 2015-06-30 |
10.32 |
$7.79 |
1.32 |
| 2015-03-31 |
10.39 |
$7.41 |
1.40 |
| 2014-12-31 |
11.29 |
$7.24 |
1.56 |
| 2014-09-30 |
9.23 |
$7.16 |
1.29 |
| 2014-06-30 |
9.38 |
$6.92 |
1.35 |
| 2014-03-31 |
9.44 |
$6.85 |
1.38 |
| 2013-12-31 |
8.99 |
$6.65 |
1.35 |
| 2013-09-30 |
7.92 |
$6.40 |
1.24 |
| 2013-06-30 |
8.20 |
$6.17 |
1.33 |
| 2013-03-31 |
8.51 |
$6.65 |
1.28 |
| 2012-12-31 |
6.68 |
$7.10 |
0.94 |
| 2012-09-30 |
6.60 |
$7.45 |
0.89 |
| 2012-06-30 |
7.67 |
$8.11 |
0.95 |
| 2012-03-31 |
9.94 |
$8.83 |
1.13 |
| 2011-12-31 |
8.22 |
$9.67 |
0.85 |
| 2011-09-30 |
6.47 |
$10.60 |
0.61 |
| 2011-06-30 |
8.55 |
$11.42 |
0.75 |
| 2011-03-31 |
10.81 |
$11.00 |
0.98 |
| 2010-12-31 |
7.14 |
$10.35 |
0.69 |
| 2010-09-30 |
5.28 |
$9.26 |
0.57 |
| 2010-06-30 |
6.09 |
$7.44 |
0.82 |
| 2010-03-31 |
6.94 |
$5.70 |
1.22 |
| 2009-12-31 |
6.76 |
$3.98 |
1.70 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MEDICAL INFO SYS |
$2.045B |
$0.656B |
|
Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
| Veeva Systems Inc. (VEEV) |
US |
$36.657B |
54.02 |
| Hims & Hers Health, Inc. (HIMS) |
US |
$10.767B |
273.78 |
| Tempus AI, Inc. (TEM) |
US |
$10.720B |
0.00 |
| Inspire Medical Systems, Inc. (INSP) |
US |
$5.261B |
102.50 |
| iRhythm Technologies (IRTC) |
US |
$3.752B |
0.00 |
| Privia Health Group, Inc. (PRVA) |
US |
$2.942B |
245.20 |
| Enovis Corporation (ENOV) |
US |
$2.428B |
16.18 |
| Clover Health Investments, Corp. (CLOV) |
US |
$2.205B |
0.00 |
| Omnicell, Inc. (OMCL) |
US |
$1.840B |
40.12 |
| Schrodinger, Inc. (SDGR) |
US |
$1.650B |
0.00 |
| Phreesia, Inc. (PHR) |
US |
$1.640B |
0.00 |
| 10x Genomics (TXG) |
US |
$1.333B |
0.00 |
| Butterfly Network, Inc. (BFLY) |
US |
$0.916B |
0.00 |
| Talkspace, Inc. (TALK) |
US |
$0.508B |
300.50 |
| Fulgent Genetics, Inc. (FLGT) |
US |
$0.503B |
0.00 |
| Standard BioTools Inc. (LAB) |
US |
$0.484B |
0.00 |
| TruBridge, Inc. (TBRG) |
US |
$0.422B |
122.87 |
| Pulmonx Corporation (LUNG) |
US |
$0.354B |
0.00 |
| Nyxoah SA (NYXH) |
BE |
$0.352B |
0.00 |
| Health Catalyst, Inc. (HCAT) |
US |
$0.318B |
0.00 |
| SOPHiA GENETICS SA (SOPH) |
CH |
$0.266B |
0.00 |
| American Well Corporation (AMWL) |
US |
$0.183B |
0.00 |
| EUDA Health Holdings Limited (EUDA) |
SG |
$0.098B |
0.00 |
| MDxHealth SA (MDXH) |
BE |
$0.088B |
0.00 |
| P3 Health Partners Inc. (PIII) |
US |
$0.075B |
0.00 |
| 111, Inc. Sponsored ADR (YI) |
CN |
$0.072B |
0.00 |
| CareCloud, Inc. (CCLD) |
US |
$0.058B |
0.00 |
| HeartBeam, Inc. (BEAT) |
US |
$0.055B |
0.00 |
| Outset Medical, Inc. (OM) |
US |
$0.047B |
0.00 |
| Zepp Health Corporation Sponsored ADR (ZEPP) |
CN |
$0.045B |
0.00 |
| SHL Telemedicine Ltd. Unsponsored ADR (SHLT) |
IL |
$0.038B |
0.00 |
| Zhongchao Inc. (ZCMD) |
CN |
$0.035B |
0.00 |
| Movano Inc. (MOVE) |
US |
$0.033B |
0.00 |
| Bullfrog AI Holdings Inc. (BFRG) |
US |
$0.025B |
0.00 |
| MSP Recovery, Inc. (MSPR) |
US |
$0.016B |
0.00 |
| Streamline Health Solutions, Inc. (STRM) |
US |
$0.015B |
0.00 |
| Precipio, Inc. (PRPO) |
US |
$0.015B |
0.00 |
| ImmunoPrecise Antibodies Ltd. (IPA) |
CA |
$0.012B |
0.00 |
| Mobile-health Network Solutions (MNDR) |
SG |
$0.012B |
0.00 |
| Strata Skin Sciences, Inc. (SSKN) |
US |
$0.011B |
0.00 |
| Predictive Oncology Inc. (POAI) |
US |
$0.010B |
0.00 |
| Syra Health Corp. (SYRA) |
US |
$0.005B |
0.00 |
| Tivic Health Systems, Inc. (TIVC) |
US |
$0.004B |
0.00 |
| HeartSciences Inc. (HSCS) |
US |
$0.004B |
0.00 |
| Healthcare Triangle, Inc. (HCTI) |
US |
$0.003B |
0.00 |
| Future Health ESG Corp. (FHLT) |
US |
$0.000B |
0.00 |
